Trevena (TRVN) Declines After FDA Posts Briefing Documents for Oliceridine

October 9, 2018 8:21 AM

Trevena (NASDAQ: TRVN) declined by ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found